Myelodysplastic Syndrome (MDS)
The most likely diagnosis is myelodysplastic syndrome (MDS), given the combination of severe microcytic anemia, leukopenia with neutropenia, elevated ferritin, and normal total iron-binding capacity in a 69-year-old patient.
Diagnostic Reasoning
This clinical presentation strongly suggests MDS based on the following key features:
Supporting Clinical Features
- Age: At 69 years old, the patient falls within the typical demographic for MDS, which predominantly affects older adults
- Cytopenias in multiple lineages: The presence of both severe anemia AND leukopenia/neutropenia indicates multilineage involvement, a hallmark of MDS 1, 2
- Iron parameters: The combination of elevated ferritin with normal TIBC is inconsistent with simple iron deficiency anemia and suggests a more complex bone marrow disorder 3
Why MDS Fits Best
According to NCCN and European LeukemiaNet guidelines, MDS diagnosis requires exclusion of other causes of cytopenia plus at least one decisive criterion: dysplasia ≥10% in one or more bone marrow lineages, blast count 5-19%, or MDS-associated karyotype 2. The multilineage cytopenias (anemia plus leukopenia/neutropenia) in an elderly patient strongly point toward this diagnosis.
Critical Next Steps
Mandatory diagnostic workup includes 1, 2:
Bone marrow aspiration and biopsy with:
- Morphologic evaluation for dysplasia in hematopoietic cell lines
- Blast enumeration
- Prussian blue stain for ring sideroblasts
- Assessment of cellularity and fibrosis
Cytogenetic analysis of bone marrow (essential for prognosis and diagnosis)
Peripheral blood smear review for dysplastic features
Flow cytometry to assess CD34+ cells and exclude PNH clone
Important Differentials to Exclude
Before confirming MDS, rule out 1, 2:
- Vitamin B12 and folate deficiency (check RBC folate/serum B12)
- HIV, parvovirus B19, hepatitis (viral serologies)
- Medication-induced cytopenias (detailed medication history)
- Exposure history (benzene, chemotherapy, radiation)
- Inherited bone marrow failure syndromes (especially in younger patients, though less likely at age 69)
Common Pitfalls to Avoid
- Do not attribute multilineage cytopenias to iron deficiency alone: While microcytic anemia can occur with iron deficiency, the presence of leukopenia/neutropenia makes this diagnosis insufficient 3
- Do not delay bone marrow examination: This is mandatory for diagnosis and cannot be substituted with peripheral blood studies alone 1, 2
- Elevated ferritin is common in MDS: This reflects both the underlying bone marrow disorder and potential transfusion-related iron overload, not primary hemochromatosis 4, 5
Prognostic Considerations
Once MDS is confirmed, cytogenetic analysis becomes critical for risk stratification and treatment planning, as specific chromosomal abnormalities (del(5q), del(20q), +8, -7/del(7q)) carry distinct prognostic implications 1, 2.